Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.75  1.15  29.49%   
About 62% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
a minute ago at businesswire.com         
Vernal Biosciences Appoints Jim Petrilla as CEO Board Director
businesswire News
a minute ago at gurufocus.com         
CRBU INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Caribou Biosciences, ...
Gurufocus Stories at Macroaxis
3 days ago at prnewswire.com         
SHAREHOLDER ALERT Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Pacira ...
prnewswire News
few days ago at finance.yahoo.com         
Should Value Investors Buy Harmony Biosciences Stock?
Yahoo News
few days ago at gurufocus.com         
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Aptose Biosciences Inc. Files 8-K Report
news
few days ago at simplywall.st         
Retail investors are Kuros Biosciences AGs biggest owners and were hit after market cap dropped CHF1...
Simply Wall St News at Macroaxis
six days ago at kalkinemedia.com         
Bacteriophage Therapy Market Projected To Witness Substantial Growth, 2025-2032 Nextbiotics, Locus B...
news
six days ago at simplywall.st         
Despite shrinking by US214m in the past week, Castle Biosciences shareholders are still up 29 percen...
Simply Wall St News at Macroaxis
six days ago at insidermonkey.com         
Avidity Biosciences, Inc. The Biotech Stock with Biggest Upside Potential
insidermonkey News
six days ago at finance.yahoo.com         
Junshi Biosciences Announces Toripalimabs Approval in Australia
Yahoo News
six days ago at gurufocus.com         
Caribou Biosciences, Inc. Sued for Securities Law Violations - Contact Levi Korsinsky ...
Gurufocus Stories at Macroaxis
over a week ago at insidermonkey.com         
Hedge Fund and Insider Trading News Bill Ackman, Scott Bessent, Alden Global Capital, Saba Capital, ...
insidermonkey News
over a week ago at finance.yahoo.com         
Marvel Biosciences Announces Notice of Allowance of Composition of Matter Patent for Its Lead Molecu...
Yahoo News
over a week ago at prnewswire.com         
CRBU LAWSUIT ALERT The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action...
prnewswire News
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account